Labcorp预计2025年销售额为138.8亿至140.5亿美元，对比市场预期的137.9亿美元，调整后每股收益为15.60至16.40美元，对比市场预期的16.02美元

财报速递2025-02-06

2025年指引假设外汇汇率截至2024年12月31日的全年有效。企业层面的指引包括当前预期的资本配置影响，包括收购、股票回购和股息。2024年Labcorp企业的收入为130.1亿美元，诊断实验室收入为101.4亿美元，生物制药实验室服务收入为29.2亿美元。2025年的收入指引包括6.7%至8.0%的增长。调整后每股收益在2024年为14.57美元，2025年指引为15.60至16.40美元。

以上内容来自Benzinga Earnings专栏，原文如下：

Guidance for 2025

The following guidance assumes foreign exchange rates effective as of December 31, 2024, for the full year. Enterprise level guidance includes the estimated impact from currently anticipated capital allocation, including acquisitions, share repurchases and dividends.

(Dollars in billions, except per share data)

	Results		2025 Guidance

	2024		Low	High
Revenue
Labcorp Enterprise (1)(2)	$13.01		6.7 %	8.0 %
Diagnostics Laboratories (3)	$10.14		6.5 %	7.7 %
Biopharma Laboratory Services (4)	$2.92		3.0 %	5.0 %


Adjusted EPS	$14.57		$15.60	$16.40

Free Cash Flow	$1.10		$1.10	$1.25

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1149955265?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-06 19:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149955265","market":"us","top_or_hot":-1,"title":"Labcorp预计2025年销售额为138.8亿至140.5亿美元，对比市场预期的137.9亿美元，调整后每股收益为15.60至16.40美元，对比市场预期的16.02美元","media":"财报速递","content":"2025年指引假设外汇汇率截至2024年12月31日的全年有效。企业层面的指引包括当前预期的资本配置影响，包括收购、股票回购和股息。2024年Labcorp企业的收入为130.1亿美元，诊断实验室收入为101.4亿美元，生物制药实验室服务收入为29.2亿美元。2025年的收入指引包括6.7%至8.0%的增长。调整后每股收益在2024年为14.57美元，2025年指引为15.60至16.40美元。<br><br>以上内容来自Benzinga Earnings专栏，原文如下：<br><html><body><p><strong>Guidance for 2025</strong></p><p>The following guidance assumes foreign exchange rates effective as of December 31, 2024, for the full year. Enterprise level guidance includes the estimated impact from currently anticipated capital allocation, including acquisitions, share repurchases and dividends.</p><figure><table><tbody><tr><td colspan=\"5\" rowspan=\"1\"><i><strong>(Dollars in billions, except per share data)</strong></i></td></tr><tr><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"2\" rowspan=\"1\"><br/><br/> </td></tr><tr><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><strong>Results</strong></td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"2\" rowspan=\"1\"><strong>2025 Guidance</strong></td></tr><tr><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td></tr><tr><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><strong>2024</strong></td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><strong>Low</strong></td><td colspan=\"1\" rowspan=\"1\"><strong>High</strong></td></tr><tr><td colspan=\"1\" rowspan=\"1\"><strong>Revenue</strong></td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td></tr><tr><td colspan=\"1\" rowspan=\"1\">Labcorp Enterprise (1)(2)</td><td colspan=\"1\" rowspan=\"1\">$13.01</td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\">6.7 %</td><td colspan=\"1\" rowspan=\"1\">8.0 %</td></tr><tr><td colspan=\"1\" rowspan=\"1\">Diagnostics Laboratories (3)</td><td colspan=\"1\" rowspan=\"1\">$10.14</td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\">6.5 %</td><td colspan=\"1\" rowspan=\"1\">7.7 %</td></tr><tr><td colspan=\"1\" rowspan=\"1\">Biopharma Laboratory Services (4)</td><td colspan=\"1\" rowspan=\"1\">$2.92</td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\">3.0 %</td><td colspan=\"1\" rowspan=\"1\">5.0 %</td></tr><tr><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td></tr><tr><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td></tr><tr><td colspan=\"1\" rowspan=\"1\"><strong>Adjusted EPS</strong></td><td colspan=\"1\" rowspan=\"1\">$14.57</td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\">$15.60</td><td colspan=\"1\" rowspan=\"1\">$16.40</td></tr><tr><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td></tr><tr><td colspan=\"1\" rowspan=\"1\"><strong>Free Cash Flow</strong></td><td colspan=\"1\" rowspan=\"1\">$1.10</td><td colspan=\"1\" rowspan=\"1\"><br/><br/> </td><td colspan=\"1\" rowspan=\"1\">$1.10</td><td colspan=\"1\" rowspan=\"1\">$1.25</td></tr></tbody></table></figure></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Labcorp预计2025年销售额为138.8亿至140.5亿美元，对比市场预期的137.9亿美元，调整后每股收益为15.60至16.40美元，对比市场预期的16.02美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLabcorp预计2025年销售额为138.8亿至140.5亿美元，对比市场预期的137.9亿美元，调整后每股收益为15.60至16.40美元，对比市场预期的16.02美元\n</h2>\n\n<h4 class=\"meta\">\n\n2025-02-06 19:54 北京时间&nbsp;&nbsp;&nbsp;<strong>财报速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2025年指引假设外汇汇率截至2024年12月31日的全年有效。企业层面的指引包括当前预期的资本配置影响，包括收购、股票回购和股息。2024年Labcorp企业的收入为130.1亿美元，诊断实验室收入为101.4亿美元，生物制药实验室服务收入为29.2亿美元。2025年的收入指引包括6.7%至8.0%的增长。调整后每股收益在2024年为14.57美元，2025年指引为15.60至16.40美元。...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LH","symbol_name":"徕博科","start_time":0,"source_url":"","article_id":"1149955265","we_media_id":"1048278264","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149955265","pubTimestamp":1738842859,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"财报速递","introduction":"每日财报追踪","home_visible":1,"id":"1048278264","head_image":"https://community-static.tradeup.com/news/decf3d8a922fc5c1c1d787bf8b36173f"},"summary":"2025年指引假设外汇汇率截至2024年12月31日的全年有效。企业层面的指引包括当前预期的资本配置影响，包括收购、股票回购和股息。2024年Labcorp企业的收入为130.1亿美元，诊断实验室收入为101.4亿美元，生物制药实验室服务收入为29.2亿美元。调整后每股收益在2024年为14.57美元，2025年指引为15.60至16.40美元。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LH":"徕博科"},"translate_title":"Labcorp expects 2025 sales of $13.88 billion to $14.05 billion, compared to consensus of $13.79 billion, and adjusted earnings per share of $15.60 to $16.40, compared to consensus of $16.02","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LH":0.9},"content_text":"2025年指引假设外汇汇率截至2024年12月31日的全年有效。企业层面的指引包括当前预期的资本配置影响，包括收购、股票回购和股息。2024年Labcorp企业的收入为130.1亿美元，诊断实验室收入为101.4亿美元，生物制药实验室服务收入为29.2亿美元。2025年的收入指引包括6.7%至8.0%的增长。调整后每股收益在2024年为14.57美元，2025年指引为15.60至16.40美元。以上内容来自Benzinga Earnings专栏，原文如下：Guidance for 2025The following guidance assumes foreign exchange rates effective as of December 31, 2024, for the full year. Enterprise level guidance includes the estimated impact from currently anticipated capital allocation, including acquisitions, share repurchases and dividends.(Dollars in billions, except per share data)     Results 2025 Guidance      2024 LowHighRevenue    Labcorp Enterprise (1)(2)$13.01 6.7 %8.0 %Diagnostics Laboratories (3)$10.14 6.5 %7.7 %Biopharma Laboratory Services (4)$2.92 3.0 %5.0 %          Adjusted EPS$14.57 $15.60$16.40     Free Cash Flow$1.10 $1.10$1.25","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149955265","isCrawlerRequest":true}